Peran Kinerja Keuangan dalam Memediasi Hubungan Efisiensi Biaya dan Struktur Modal terhadap Nilai Perusahaan Farmasi di Indonesia 2020-2024

Authors

  • Fajra Azkia Cahya Al Aulia Universitas Primagraha
  • Rafly Ramadhan Universitas Primagraha
  • Muhamad Haris Anur Suhada Universitas Primagraha
  • Santinah Santinah Universitas Primagraha
  • Bambang Hermawan Universitas Primagraha

DOI:

https://doi.org/10.55606/jupsim.v5i3.7763

Keywords:

Company Performance, Cost Efficiency, Firm Value, Capital Structure, Mediation

Abstract

Using companyiperformance as an intervening variable, this study examines the impact of capital structure and cost efficiency on firm value in pharmaceutical enterprises between 2020 and 2024. The Operating Expenses to Operating Income ratio (BOPO) was used to measure cost efficiency; the Debt to Asset Ratio (DAR) was used to measure capital structure; Return on Assets (ROA) was used as a proxy for corporate performance; and the Price to Book worth (PBV) ratio was used to determine firm worth. Panel data regression analysis was used in a quantitative study design. The Random Effect Model (REM) was chosen for substructure 2, while the Common Effect Model (CEM) was determined to be the best model for substructure 1 based on the model selection process. The Sobel test was used to further assess the mediating influence of business performance. The empirical results show that BOPO and DAR together significantly affect ROA. On the other hand, BOPO, DAR, and ROA were not observed to have a significant impact on PBV in substructure 2. Additionally, the Sobel test shows that the relationship between BOPO, DAR, and firm value is not mediated by ROA.

References

Wijayanti, S. A., & Setiawati, E. (2024). Pengaruh struktur modal, keputusan investasi, profitabilitas sebagai variabel mediasi terhadap nilai perusahaan: Studi kasus pada perusahaan manufaktur sub sektor makanan dan minuman yang terdaftar di Bursa Efek Indonesia tahun 2020–2022. Jurnal Bisnis, Bisnis dan Ekonomi (JBBE), 18(1), 98–109. https://doi.org/10.46306/jbbe.v18i1.679

Warta Ekonomi. (2025). Turun 58,10%, rugi Kimia Farma (KAEF) sisa Rp95 miliar di semester I 2025.

Sukirno, S., & Wahyuni, R. (2026). Post-pandemic valuation anomaly: Why current ratio failure to mediate ROA and DER on PBV in the chemical sector on the IDX. International Journal of Science and Environment (IJSE), 6(1), 991–998.

Sofiani, L., & Siregar, E. M. (2022). Analisis pengaruh ROA, CR dan DAR terhadap nilai perusahaan sektor makanan dan minuman. Jurnal Ilmiah Akuntansi Kesatuan, 10(1), 9–16.

Salsabilla, A., Sinaga, R. N., Nasution, S. Z. A. P., Musyafa, F., & Hasibuan, M. M. P. (2024). Pengaruh CAR, NPF, BOPO terhadap ROA Bank Syariah Indonesia (2019–2023). Al-Ihsan: Jurnal Bisnis dan Ekonomi Syariah.

Risdwiyanto, A. & Kurniyati, Y. (2015). Strategi Pemasaran Perguruan Tinggi Swasta di Kabupaten Sleman Yogyakarta Berbasis Rangsangan Pemasaran. Jurnal Maksipreneur: Manajemen, Koperasi, dan Entrepreneurship, 5(1), 1-23. http://dx.doi.org/10.30588/SOSHUMDIK.v5i1.142.

Putri, R. G., & Darto. (2025). Determinasi nilai perusahaan pada perusahaan sub industri farmasi di Indonesia. Jurnal Pendidikan Tambusai, 9(2), 13073–13083.

PT Bursa Efek Indonesia. (2020–2024). Laporan Keuangan Tahunan Perusahaan Sub Sektor Farmasi yang Terdaftar di Bursa Efek Indonesia. Diakses dari https://www.idx.co.id

Muhajir, A., Miyasto, & Mawardi, W. (2018). A study on the company value of public banks listed in the Indonesian Stock Exchange between 2010–2015. Jurnal Bisnis Strategi, 26(1), 13–27. https://doi.org/10.14710/jbs.26.1.13-27

Kasmir. (2019). Analisis Laporan Keuangan. PT RajaGrafindo Persada.

Jati, W., Oktrima, B., & Ariyanti, E. (2022). Pengaruh Net Interest Margin (NIM) dan Biaya Operasional dan Pendapatan Operasional (BOPO) terhadap Return on Asset (ROA) pada PT Bank Central Asia, Tbk periode 2010–2020. Jurnal Ilmiah Swara MaNajemen (Swara Mahasiswa Manajemen), 2(4), 509–518. https://doi.org/10.32493/jism.v2i4.25618

Hakim, L., Sari, P. R. K., & Yunita, V. A. (2019). Pengaruh NPL dan BOPO terhadap ROA pada Perbankan yang Terdaftar di Bursa Efek Indonesia 2013–2017. Jurnal Manajemen dan Bisnis, 2(1). https://doi.org/10.37673/jmb.v2i1.282

Fei, C., & Wirianata, H. (2026). Pengaruh struktur modal, ukuran perusahaan dan likuiditas terhadap nilai perusahaan dengan profitabilitas sebagai variabel intervening. Jurnal Akuntansi, Keuangan dan Manajemen (JAFM), 7(1), 95–106. https://doi.org/10.38035/jafm.v7i1

Febrianti, C., & Suartini, S. (2021). Pengaruh Current Ratio (CR) dan Debt to Asset Ratio (DAR) terhadap Return on Asset (ROA). Journal of Economic, Business and Accounting (COSTING), 4(2), 492–497.

Devina, M., & Purnama, M. (2022). Analisis pengaruh current ratio, return on asset, debt ratio, dan inventory turnover terhadap nilai perusahaan.... NIKAMABI: Jurnal Ekonomi dan Bisnis, 1(2).

Detik Finance. (2025, 8 Mei). Holding BUMN farmasi masih rugi Rp1 triliun.

Brigham,E.F.,&Houston,J.(2016). Fundamentals of Financial Management (15th ed.). Cengage Learning.

Asmin, E. A., Kartini, T., & Alvianingsih, A. (2024). Pengaruh debt to asset ratio (DAR), return on asset (ROA), dan size terhadap nilai perusahaan (PBV).... Promosi: Jurnal Program Studi Pendidikan Ekonomi, 12(2).

ANTARA News. (2025). Phapros berbalik dari rugi jadi cetak laba Rp27,44 miliar di 2025.

ANTARA News. (2025). Phapros (PEHA) ungkap tantangan yang dihadapi industri farmasi di 2025.

Downloads

Published

2026-09-01

How to Cite

Fajra Azkia Cahya Al Aulia, Rafly Ramadhan, Muhamad Haris Anur Suhada, Santinah Santinah, & Bambang Hermawan. (2026). Peran Kinerja Keuangan dalam Memediasi Hubungan Efisiensi Biaya dan Struktur Modal terhadap Nilai Perusahaan Farmasi di Indonesia 2020-2024. Jurnal Publikasi Sistem Informasi Dan Manajemen Bisnis, 5(3), 17–36. https://doi.org/10.55606/jupsim.v5i3.7763